Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma

被引:151
作者
Wang, Lei [1 ]
Guo, Zhang-Yan [2 ]
Zhang, Rui [1 ]
Xin, Bo [3 ]
Chen, Rui [1 ]
Zhao, Jing [1 ]
Wang, Tao [2 ]
Wen, Wei-Hong [2 ]
Jia, Lin-Tao [1 ]
Yao, Li-Bo [1 ]
Yang, An-Gang [2 ]
机构
[1] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China
[3] 88 Hosp PLA, Dept Oncol, Tai An 271000, Shandong, Peoples R China
关键词
GENE-EXPRESSION; STEM-CELLS; SELF-RENEWAL; NANOG; TRANSCRIPTION; PLURIPOTENCY; OCT-3/4; BIOLOGY; MARKER; SOX2;
D O I
10.1093/carcin/bgt139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The POU transcription factor OCT4 is a pleiotropic regulator of gene expression in embryonic stem cells. Recent studies demonstrated that OCT4 is aberrantly expressed in multiple types of human cancer; however, the underlying molecular mechanism remains largely unknown. In this study, we report that OCT4-pg4, a pseudogene of OCT4, is abnormally activated in hepatocellular carcinoma (HCC). The expression level of OCT4-pg4 is positively correlated with that of OCT4, and both gene transcripts can be directly targeted by a tumor-suppressive micro RNA miR-145. We find that the non-coding RNA OCT4-pg4 is biologically active, as it can upregulate OCT4 protein level in HCC. Mechanistic analysis revealed that OCT4-pg4 functions as a natural micro RNA sponge to protect OCT4 transcript from being inhibited by miR-145. In addition, our study also showed that OCT4-pg4 can promote growth and tumorigenicity of HCC cells, thus exerting an oncogenic role in hepatocarcinogenesis. Furthermore, survival analysis suggests that high OCT4-pg4 level is significantly correlated with poor prognosis of HCC patients. Taken together, our finding adds a new layer of post-transcriptional regulation of OCT4 and sheds new light on the treatment of human HCC.
引用
收藏
页码:1773 / 1781
页数:9
相关论文
共 49 条
[1]   OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer [J].
Atlasi, Yaser ;
Mowla, Seyed J. ;
Ziaee, Seyed A. M. ;
Bahrami, Ahmad-Reza .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) :1598-1602
[2]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]  
BRISTOW J, 1993, J BIOL CHEM, V268, P12919
[4]   Absence of OCT4 expression in somatic tumor cell lines [J].
Cantz, Tobias ;
Key, Goeran ;
Bleidissel, Martina ;
Gentile, Luca ;
Han, Dong Wook ;
Brenne, Alexandra ;
Schoeler, Hans R. .
STEM CELLS, 2008, 26 (03) :692-697
[5]   OCT4: biological functions and clinical applications as a marker of germ cell neoplasia [J].
Cheng, L. ;
Sung, M-T ;
Cossu-Rocca, P. ;
Jones, T. D. ;
MacLennan, G. T. ;
De Jong, J. ;
Lopez-Beltran, A. ;
Montironi, R. ;
Looljenga, L. H. J. .
JOURNAL OF PATHOLOGY, 2007, 211 (01) :1-9
[6]   Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation [J].
Chiba, Tetsuhiro ;
Zheng, Yun-Wen ;
Kita, Kaoru ;
Yokosuka, Osamu ;
Saisho, Hiromitsu ;
Onoidera, Masafumi ;
Miyoshi, Hiroyuki ;
Nakano, Masayuki ;
Zen, Yoh ;
Nakanuma, Yasuni ;
Nakauchi, Hiromitsu ;
Iwama, Atsushi ;
Taniguchi, Hideki .
GASTROENTEROLOGY, 2007, 133 (03) :937-950
[7]   MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells [J].
Ebert, Margaret S. ;
Neilson, Joel R. ;
Sharp, Phillip A. .
NATURE METHODS, 2007, 4 (09) :721-726
[8]   Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma [J].
Ezeh, UI ;
Turek, PJ ;
Reijo, RA ;
Clark, AT .
CANCER, 2005, 104 (10) :2255-2265
[9]   Target mimicry provides a new mechanism for regulation of microRNA activity [J].
Franco-Zorrilla, Jose Manuel ;
Valli, Adrian ;
Todesco, Marco ;
Mateos, Isabel ;
Puga, Maria Isabel ;
Rubio-Somoza, Ignacio ;
Leyva, Antonio ;
Weigel, Detlef ;
Garcia, Juan Antonio ;
Paz-Ares, Javier .
NATURE GENETICS, 2007, 39 (08) :1033-1037
[10]   Oct-3/4 is a dose-dependent oncogenic fate determinant [J].
Gidekel, S ;
Pizov, G ;
Bergman, Y ;
Pikarsky, E .
CANCER CELL, 2003, 4 (05) :361-370